Right ventricular expression of NT‐proBNP adds predictive value to REVEAL score in patients with pulmonary arterial hypertension

AIMS: The Registry to Evaluate Early and Long‐Term PAH Disease Management (REVEAL) risk scores differentiate survivals in patients with pulmonary arterial hypertension (PAH). However, measurements of N‐terminal pro B‐type natriuretic peptide (NT‐proBNP) in the peripheral blood may not adequately ref...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Wei‐Ting, Shih, Jhih‐Yuan, Hong, Chon‐Seng, Lin, Yu‐Wen, Chen, Yi‐Chen, Ho, Chung‐Han, Chen, Zhih‐Cherng, Roan, Jun‐Neng, Hsu, Chih‐Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318442/
https://www.ncbi.nlm.nih.gov/pubmed/33955184
http://dx.doi.org/10.1002/ehf2.13410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318442/
https://www.ncbi.nlm.nih.gov/pubmed/33955184
http://dx.doi.org/10.1002/ehf2.13410

Ejemplares similares